Pharmafile Logo

What to Consider When Conducting Patient Research in Saudi Arabia

The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.


Conducting market research with patients in any market can be a challenge, requiring sensitivity and consideration for language, culture, religion, as well as for other emotional, behavioural and environmental factors that might impact patients’ behaviour.

In The Kingdom of Saudi Arabia (KSA), where religion and culture are central to society and there are strict laws governing behaviour, patient research can be uniquely challenging. However, as the fastest growing pharma market in the Middle East, it is critical that those who want to leverage opportunities in this Arab state understand patient needs and behaviour. In this article, we will outline the factors to consider when designing a patient research programme, based on our experience and knowledge of the region.

Find out more:
www.researchpartnership.com/news/2016/01/article-what-to-consider-when-conducting-patient-res…


This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard